BARI, ELIA
 Distribuzione geografica
Continente #
NA - Nord America 3.267
AS - Asia 2.249
EU - Europa 1.600
SA - Sud America 298
AF - Africa 142
OC - Oceania 5
Totale 7.561
Nazione #
US - Stati Uniti d'America 3.176
CN - Cina 1.037
SG - Singapore 496
IE - Irlanda 490
VN - Vietnam 238
HK - Hong Kong 235
IT - Italia 229
RU - Federazione Russa 225
BR - Brasile 222
DE - Germania 190
FR - Francia 126
FI - Finlandia 106
ZA - Sudafrica 105
GB - Regno Unito 89
IN - India 62
CA - Canada 58
SE - Svezia 37
AR - Argentina 31
BD - Bangladesh 30
MX - Messico 26
BE - Belgio 22
ID - Indonesia 22
NL - Olanda 22
JP - Giappone 21
IQ - Iraq 20
ES - Italia 16
CO - Colombia 12
EC - Ecuador 12
TR - Turchia 12
PH - Filippine 10
PK - Pakistan 10
PL - Polonia 10
MA - Marocco 8
SA - Arabia Saudita 8
CL - Cile 7
CH - Svizzera 6
KE - Kenya 6
KR - Corea 6
TN - Tunisia 6
UA - Ucraina 6
AT - Austria 5
CZ - Repubblica Ceca 5
MU - Mauritius 5
MY - Malesia 5
PY - Paraguay 5
UZ - Uzbekistan 5
VE - Venezuela 5
AZ - Azerbaigian 4
LT - Lituania 4
PE - Perù 4
TH - Thailandia 4
AU - Australia 3
CR - Costa Rica 3
ET - Etiopia 3
IR - Iran 3
LB - Libano 3
BH - Bahrain 2
DZ - Algeria 2
EG - Egitto 2
HR - Croazia 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
AE - Emirati Arabi Uniti 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GR - Grecia 1
IL - Israele 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
MD - Moldavia 1
ML - Mali 1
MW - Malawi 1
NP - Nepal 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
UG - Uganda 1
Totale 7.561
Città #
Chandler 528
Dublin 484
Ashburn 399
San Jose 320
Beijing 247
Singapore 246
Dallas 238
Hong Kong 228
Nanjing 172
Johannesburg 99
New York 98
Boardman 95
Princeton 88
Lawrence 87
Medford 86
Lauterbourg 83
Helsinki 79
Ho Chi Minh City 78
Shanghai 74
Los Angeles 73
Wilmington 63
Munich 59
Pavia 59
Hanoi 55
Ann Arbor 54
Nanchang 42
Redondo Beach 39
Council Bluffs 38
Shenyang 37
Toronto 37
Dearborn 36
Moscow 35
Changsha 34
Hebei 34
Basingstoke 31
Frankfurt am Main 31
Hangzhou 31
Buffalo 30
Jiaxing 30
Orem 30
Washington 27
São Paulo 24
Turku 24
Jacksonville 21
Brussels 20
Tokyo 20
Da Nang 19
Milan 19
Tianjin 18
Chennai 17
Guangzhou 17
Piemonte 16
Chicago 15
Chongqing 15
Manchester 15
Redwood City 14
Amsterdam 13
Phoenix 13
Santa Clara 12
Stockholm 12
The Dalles 12
Mumbai 11
Rome 11
Des Moines 10
Houston 10
Norwalk 10
San Francisco 10
Brooklyn 9
Columbus 9
Dhaka 9
Düsseldorf 9
Kunming 9
Mexico City 9
Medellín 8
Poplar 8
Warsaw 8
Woodbridge 8
Fairfield 7
Falkenstein 7
Jinan 7
London 7
Montreal 7
Quito 7
Xian 7
Atlanta 6
Denver 6
Hefei 6
Jakarta 6
New Delhi 6
Porto Alegre 6
San Mateo 6
Travaco Siccomario 6
Ankara 5
Baghdad 5
Berlin 5
Bắc Ninh 5
Cambridge 5
Hải Dương 5
Nairobi 5
Ningbo 5
Totale 5.255
Nome #
3D Bioprinted Scaffolds Containing Mesenchymal Stem/Stromal Lyosecretome: Next Generation Controlled Release Device for Bone Regenerative Medicine 150
Lyosecretome for use in the treatment of autoimmune diseases 139
Adipose Mesenchymal Extracellular Vesicles as Alpha-1-Antitrypsin Physiological Delivery Systems for Lung Regeneration 137
Lyosecretome for use in the treatment or prevention of skin aging by inhibiting elastase and tyrosinase activity 136
Lyosecretome for use in the treatment of degenerative osteoarticular diseases and/or degenerative intervertebral disc disease. 134
3D Bioprinted Scaffolds for controlled release of Mesenchymal Stem/Stromal Lyo-secretome in Bone Regeneration 125
Canine lyo-secretome for osteoarticular regeneration in veterinary medicine: pilot-production and in vitro efficacy 118
Combining Inulin and Cyclodextrin for colon drug release 116
Silk fibroin nanoparticles for Celecoxib and Curcumin delivery: ROS-scavenging and anti-inflammatory activities in an in vitro model of osteoarthrit 115
Mesenchymal Extracellular Vesicles as Alpha-1-antitrypsin physiological delivery systems for lung regeneration 115
Association of silk sericin and platelet lysate: Premises for the formulation of wound healing active medications 113
Lyosecretome for use in the treatment of alpha-1-antitrypsin deficiency associated diseases 113
Controlled release of celecoxib from inulin based micelles 113
Freeze-dried MSC-secretome contains active alpha-1-antitrypsin for treatment of deficiency pulmonary diseases 109
Chromatographic profiling of silk sericin for biomedical and cosmetic use by complementary hydrophylic, reversed phase and size exclusion chromatographic methods 108
Equine freeze-dried secretome for joint regeneration in veterinary medicine: production process and in vitro efficacy 107
Freeze-dried pharmaceutical formulations containing mesenchymal exosomes for acellular MSC immunomodulant therapy 106
Alternative culture media and cold-drying for obtaining high biological value Arthrospira platensis (Cyanobacteria) 106
Polyphenols-Loaded Sericin Self-Assembling Nanoparticles: A Slow-Release for Regeneration by Tissue-Resident Mesenchymal Stem/Stromal Cells 104
cRGD-Functionalized Silk Fibroin Nanoparticles: A Strategy for Cancer Treatment with a Potent Unselective Naphthalene Diimide Derivative 103
Human engineered cartilage and decellularized matrix as an alternative to animal osteoarthritis model 103
Cross-linked silk sericin microparticles as bioactive delivery system: formulation and in vitro cytotoxicity 103
Silk fibroin nanoparticles for Celecoxib and Curcumin delivery: in vitro efficacy in an osteoarthritis model 102
Crocetin as New Cross-Linker for Bioactive Sericin Nanoparticles 102
Processo per isolare e liofilizzare vescicole extracellulari 101
Technological Development of Freeze-dried Mesenchymal Stem Cell Secretome Formulations 101
Silk sericin and platelet lysate for intervertebral disc cell culture 100
Mesenchymal stem/stromal cell Lyosecretome for next generation cell-free regenerative nanomedicine 98
MSC extracellular vesicles for treatment of alpha-1-antitrypsin deficiency pulmonary diseases 97
Canine mesenchymal Lyosecretome production and clinical use in osteoarthritic dogs. 97
Freeze-dried MSC-secretome for use in the treatment of alpha-1-antitrypsin deficiency pulmonary diseases 96
Canine mesenchymal stem cell lyo-secretome: in vitro potency evaluation and in vivo preliminary application in dogs with naturally occurring osteoarthritis 96
Characterization and antioxidant activity of essential oil of four sympatric orchid species 94
Silk Fibroin Nanoparticle Functionalized with Arg-Gly-Asp cyclopentapeptide: Tumor specific Active Targeting 92
Auricchio F, Bari E, Conti M, Perteghella S, Scocozza F, Sorlini M, Torre ML. Scaffold per la rigenerazione tissutale, in particolare per la rigenerazione ossea, e relativo metodo di fabbricazione. 92
Nanoparticles for use in the redirection against the tumour of a non-tumour-specific immune response, based on a pre-existing immunity 91
Equine Mesenchymal Stem/Stromal Cells Freeze-Dried Secretome (Lyosecretome) for the Treatment of Musculoskeletal Diseases: Production Process Validation and Batch Release Test for Clinical Use 91
Design and development of a hepatic lyo-dECM powder as a biomimetic component for 3D-printable hybrid hydrogels 90
In vitro cytotoxicity and potency of freeze-dried MSC-secretome (Lyosecretome). 89
Freeze-dried MSC-secretome (Lyosecretome) for regenerative medicine applications: pharmaceutical development. 89
Silk Fibroin Nanoparticle Functionalization with Arg-Gly-Asp cyclopentapeptide Promotes Active Targeting for Tumor Site-Specific Delivery 89
Osteoinductive and osteoconductive properties of 3D Printed scaffolds containing Mesenchymal Stem/Stromal Lyosecretome 89
Efficacy of sponge-like dressing containing MSC lyo-secretome in a wound healing murine model 87
In vitro efficacy of platelet lysate in association with silk sericin for intervertebral disk regeneration 85
Efficacy of a freeze-dried product based on MSC-secretome (Lyosecretome) in a wound healing murine model. 85
Mesenchymal stem/stromal cell Lyosecretome for next generation cell-free regenerative nanomedicine: in vitro cytotoxicity and potency 84
Isolation and characterization of B. mori silk sericin for topical applications 84
Sericin microparticles as bioactive carriers for local drug delivery: in vitro cytocompatibility profile 83
Freeze-dried and GMP-compliant pharmaceuticals containing mesenchymal exosomes for acellular MSC immunomodulant therapy 82
Production, characterization, and in vitro efficacy of a canine lyo-secretome injectable formulation for osteoarticular regeneration 82
Synthesis of differently bioconjugated novel c-RGD antagonist 82
Mesenchymal Stromal Cell Secretome for Post-COVID-19 Pulmonary Fibrosis: A New Therapy to Treat the Long-Term Lung Sequelae? 82
Silk sericin: from textile waste material to dermatological and cosmetic applications 82
Pilot production of mesenchymal stem/stromal freeze-dried secretome for cell-free regenerative nanomedicine: a validated GMP-compliant process. 81
Freeze-dried and GMP-compliant pharmaceuticals containing exosomes for acellular mesenchymal stromal cell immunomodulant therapy 79
Production, characterization, and in vitro efficacy of canine and equine lyo-secretome injectable formulation in regenerative medicine 79
Freeze-dried secretome from mesenchymal stromal cells: a phase I clinical trial for equine and canine musculoskeletal diseases 78
Preparation and characterization of polyphenols-loaded silk sericin self-assembling nanosystems 73
Pharmaceutical development of mesenchymal extracellular vescicle formulations 71
Sponge-like formulations containing MSC lyo-secretome: efficacy in a wound healing murine model 71
From mesenchymal stem/stromal cells to cell products: pharmaceutical evelompment of secretome as new biological medicinal product 70
Scaffold for tissue regeneration, particularly for bone regeneration, and manufacturing method thereof. 70
Silk Fibroin Nanoparticle to Redirected Immunity Against Cancer 69
Veterinary Regenerative Medicine for Musculoskeletal Disorders: Can Mesenchymal Stem/Stromal Cells and Their Secretome Be the New Frontier? 69
Mesenchymal stem/stromal cell secretome for lung regeneration: The long way through “pharmaceuticalization” for the best formulation. 67
Silk-sericin Nano-drug Delivery Systems 67
Scaffold for tissue regeneration, particularly for bone regeneration, and manufacturing method thereof. 65
Pharmaceutical development of freeze-dried extracellular vesicles. 64
A new human platelet lysate for mesenchymal stem cell production compliant with Good Manufacturing Practice conditions preserve chemical characteristics and biological activity of lyo-secretome isolated by ultrafiltration 64
Osteoinductive and osteoconductive properties of titanium cages containing Mesenchymal Stem/Stromal Lyosecretome. 64
From mesenchymal stem/stromal cells to cell products: pharmaceutical development of secretome as new biological medicinal product 62
From Bench to Bedside: The Long Way Towards GMP Scale-up, Preclinical and Clinical Trials for Silk-based Drug Delivery Systems 62
Silk-fibroin Nano-drug Delivery Systems 62
Mesenchymal stem/stromal cell Lyosecretome for next generation cell-free regenerative nanomedicine: efficacy in a murine model of wound healing 60
Prediction of the mechanical response of a 3D (bio)printed hybrid scaffold for improving bone tissue regeneration by structural finite element analysis 58
Stem cell-extracellular vesicles loading silk/curcumin nanoparticles for drug delivery 58
Silk-fibroin Micro-drug Delivery Systems 58
GMP validation of production process for freeze-dried secretome from bone marrow mesenchymal stem/stromal cells 58
Osteoinductive and osteoconductive properties of Biohybrid Bovine Bone Matrix containing Mesenchymal Stem/Stromal Cell Lyosecretome 57
The Genes–Stemness–Secretome Interplay in Malignant Pleural Mesothelioma: Molecular Dynamics and Clinical Hints 57
Scaffold per la rigenerazione ossea e relativo metodo di fabbricazione 55
Silk 54
Extracellular vesicles for lung regeneration in alpha-1-antitrypsin deficiency 50
Silk fibroin nanoparticles to redirect immunity against different cancers: proof of concept in a murine model. 50
Growth Factors Delivery System for Skin Regeneration: An Advanced Wound Dressing 49
From mesenchymal stem/stromal cells to cell products: pharmaceutical development of secretome as new biological medicinal product 48
Mesenchymal Stromal Cell Secretome for Severe COVID-19 Infections: Premises for the Therapeutic Use 47
Silk-sericin Micro-drug Delivery Systems 46
GMP validation of production process for freeze-dried secretome from bone marrow mesenchymal stem/stromal cells 45
Silk-based Drug Delivery Systems 44
GMP-compliant sponge like dressing containing MSC lyo-secretome: proteomic network of healing in a murine wound model 31
Totale 7.699
Categoria #
all - tutte 31.184
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.184


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202142 0 0 0 0 0 0 0 0 0 14 13 15
2021/2022480 1 3 51 10 4 20 6 31 24 5 96 229
2022/20231.369 187 111 27 94 93 141 4 63 589 7 26 27
2023/2024629 68 96 31 37 52 190 60 36 3 19 24 13
2024/20251.411 31 103 42 36 40 162 58 87 332 81 151 288
2025/20262.960 249 212 365 310 376 137 640 212 258 201 0 0
Totale 7.699